Multivariable Association Between Oral Microbiome α-diversity and Oral HPV Infection Among 20–59 Year Olds, National Health and Nutrition Examination Survey, 2009–2012
Population . | Observed ASVs . | Faith's Phylogenetic Diversity . | Shannon-Weiner Index . | Inverse Simpson Index . | ||||
---|---|---|---|---|---|---|---|---|
aOR (95% CI) . | P Value . | aOR (95% CI) . | P Value . | aOR (95% CI) . | P Value . | aOR (95% CI) . | P Value . | |
Any oral HPV | ||||||||
Overall | 0.999 (.996–1.001) | .340 | 0.97 (.94–1.00) | .090 | 0.95 (.80–1.13) | .552 | 1.006 (.989–1.024) | .476 |
Male | 0.997 (.994–1.000) | .049 | 0.95 (.92–.98) | .001 | 0.92 (.75–1.12) | .369 | 1.001 (.980–1.023) | .918 |
Female | 1.004 (.998–1.001) | .216 | 1.05 (.96–1.14) | .284 | 1.05 (.67–1.64) | .830 | 1.024 (.976–1.074) | .332 |
High-risk oral HPV | ||||||||
Overall | 0.996 (.992–.999) | .046 | 0.95 (.90–.99) | .016 | 0.86 (.69–1.06) | .160 | 1.001 (.977–1.026) | .929 |
Male | 0.995 (.991–.999) | .007 | 0.93 (.89–.97) | .001 | 0.86 (.69–1.07) | .164 | 1.001 (.976–1.028) | .911 |
Female | 1.009 (.990–1.012) | .874 | 1.02 (.89–1.16) | .795 | 0.91 (.50–1.63) | .734 | 1.007 (.937–1.081) | .847 |
Oral HPV-16/18 | ||||||||
Overall | 1.001 (.993–1.009) | .816 | 1.02 (.92–1.14) | .661 | 0.93 (.57–1.52) | .774 | 0.987 (.941–1.035) | .580 |
Male | 0.999 (.989–1.009) | .829 | 1.00 (.88–1.15) | .968 | 0.87 (.49–1.56) | .629 | 0.973 (.921–1.028) | .322 |
Female | 1.009 (.990–1.029) | .347 | 1.10 (.85–1.35) | .371 | 1.39 (.54–3.55) | .480 | 1.050 (.967–1.140) | .234 |
Population . | Observed ASVs . | Faith's Phylogenetic Diversity . | Shannon-Weiner Index . | Inverse Simpson Index . | ||||
---|---|---|---|---|---|---|---|---|
aOR (95% CI) . | P Value . | aOR (95% CI) . | P Value . | aOR (95% CI) . | P Value . | aOR (95% CI) . | P Value . | |
Any oral HPV | ||||||||
Overall | 0.999 (.996–1.001) | .340 | 0.97 (.94–1.00) | .090 | 0.95 (.80–1.13) | .552 | 1.006 (.989–1.024) | .476 |
Male | 0.997 (.994–1.000) | .049 | 0.95 (.92–.98) | .001 | 0.92 (.75–1.12) | .369 | 1.001 (.980–1.023) | .918 |
Female | 1.004 (.998–1.001) | .216 | 1.05 (.96–1.14) | .284 | 1.05 (.67–1.64) | .830 | 1.024 (.976–1.074) | .332 |
High-risk oral HPV | ||||||||
Overall | 0.996 (.992–.999) | .046 | 0.95 (.90–.99) | .016 | 0.86 (.69–1.06) | .160 | 1.001 (.977–1.026) | .929 |
Male | 0.995 (.991–.999) | .007 | 0.93 (.89–.97) | .001 | 0.86 (.69–1.07) | .164 | 1.001 (.976–1.028) | .911 |
Female | 1.009 (.990–1.012) | .874 | 1.02 (.89–1.16) | .795 | 0.91 (.50–1.63) | .734 | 1.007 (.937–1.081) | .847 |
Oral HPV-16/18 | ||||||||
Overall | 1.001 (.993–1.009) | .816 | 1.02 (.92–1.14) | .661 | 0.93 (.57–1.52) | .774 | 0.987 (.941–1.035) | .580 |
Male | 0.999 (.989–1.009) | .829 | 1.00 (.88–1.15) | .968 | 0.87 (.49–1.56) | .629 | 0.973 (.921–1.028) | .322 |
Female | 1.009 (.990–1.029) | .347 | 1.10 (.85–1.35) | .371 | 1.39 (.54–3.55) | .480 | 1.050 (.967–1.140) | .234 |
Values in bold are statistically significant at the P < .05 level. Abbreviations: aOR, adjusted odds ratio; ASVs, amplicon sequence variants; CI, confidence interval; HPV, human papillomavirus.
Multivariable Association Between Oral Microbiome α-diversity and Oral HPV Infection Among 20–59 Year Olds, National Health and Nutrition Examination Survey, 2009–2012
Population . | Observed ASVs . | Faith's Phylogenetic Diversity . | Shannon-Weiner Index . | Inverse Simpson Index . | ||||
---|---|---|---|---|---|---|---|---|
aOR (95% CI) . | P Value . | aOR (95% CI) . | P Value . | aOR (95% CI) . | P Value . | aOR (95% CI) . | P Value . | |
Any oral HPV | ||||||||
Overall | 0.999 (.996–1.001) | .340 | 0.97 (.94–1.00) | .090 | 0.95 (.80–1.13) | .552 | 1.006 (.989–1.024) | .476 |
Male | 0.997 (.994–1.000) | .049 | 0.95 (.92–.98) | .001 | 0.92 (.75–1.12) | .369 | 1.001 (.980–1.023) | .918 |
Female | 1.004 (.998–1.001) | .216 | 1.05 (.96–1.14) | .284 | 1.05 (.67–1.64) | .830 | 1.024 (.976–1.074) | .332 |
High-risk oral HPV | ||||||||
Overall | 0.996 (.992–.999) | .046 | 0.95 (.90–.99) | .016 | 0.86 (.69–1.06) | .160 | 1.001 (.977–1.026) | .929 |
Male | 0.995 (.991–.999) | .007 | 0.93 (.89–.97) | .001 | 0.86 (.69–1.07) | .164 | 1.001 (.976–1.028) | .911 |
Female | 1.009 (.990–1.012) | .874 | 1.02 (.89–1.16) | .795 | 0.91 (.50–1.63) | .734 | 1.007 (.937–1.081) | .847 |
Oral HPV-16/18 | ||||||||
Overall | 1.001 (.993–1.009) | .816 | 1.02 (.92–1.14) | .661 | 0.93 (.57–1.52) | .774 | 0.987 (.941–1.035) | .580 |
Male | 0.999 (.989–1.009) | .829 | 1.00 (.88–1.15) | .968 | 0.87 (.49–1.56) | .629 | 0.973 (.921–1.028) | .322 |
Female | 1.009 (.990–1.029) | .347 | 1.10 (.85–1.35) | .371 | 1.39 (.54–3.55) | .480 | 1.050 (.967–1.140) | .234 |
Population . | Observed ASVs . | Faith's Phylogenetic Diversity . | Shannon-Weiner Index . | Inverse Simpson Index . | ||||
---|---|---|---|---|---|---|---|---|
aOR (95% CI) . | P Value . | aOR (95% CI) . | P Value . | aOR (95% CI) . | P Value . | aOR (95% CI) . | P Value . | |
Any oral HPV | ||||||||
Overall | 0.999 (.996–1.001) | .340 | 0.97 (.94–1.00) | .090 | 0.95 (.80–1.13) | .552 | 1.006 (.989–1.024) | .476 |
Male | 0.997 (.994–1.000) | .049 | 0.95 (.92–.98) | .001 | 0.92 (.75–1.12) | .369 | 1.001 (.980–1.023) | .918 |
Female | 1.004 (.998–1.001) | .216 | 1.05 (.96–1.14) | .284 | 1.05 (.67–1.64) | .830 | 1.024 (.976–1.074) | .332 |
High-risk oral HPV | ||||||||
Overall | 0.996 (.992–.999) | .046 | 0.95 (.90–.99) | .016 | 0.86 (.69–1.06) | .160 | 1.001 (.977–1.026) | .929 |
Male | 0.995 (.991–.999) | .007 | 0.93 (.89–.97) | .001 | 0.86 (.69–1.07) | .164 | 1.001 (.976–1.028) | .911 |
Female | 1.009 (.990–1.012) | .874 | 1.02 (.89–1.16) | .795 | 0.91 (.50–1.63) | .734 | 1.007 (.937–1.081) | .847 |
Oral HPV-16/18 | ||||||||
Overall | 1.001 (.993–1.009) | .816 | 1.02 (.92–1.14) | .661 | 0.93 (.57–1.52) | .774 | 0.987 (.941–1.035) | .580 |
Male | 0.999 (.989–1.009) | .829 | 1.00 (.88–1.15) | .968 | 0.87 (.49–1.56) | .629 | 0.973 (.921–1.028) | .322 |
Female | 1.009 (.990–1.029) | .347 | 1.10 (.85–1.35) | .371 | 1.39 (.54–3.55) | .480 | 1.050 (.967–1.140) | .234 |
Values in bold are statistically significant at the P < .05 level. Abbreviations: aOR, adjusted odds ratio; ASVs, amplicon sequence variants; CI, confidence interval; HPV, human papillomavirus.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.